Ernexa Therapeutics (ERNAW) EBIT Margin Growth (3y) (2013 - 2023)
Ernexa Therapeutics (ERNAW) EBIT Margin Growth (3y) (2013 - 2023) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-40,178.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
530.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Ernexa Therapeutics |
- |
- |
- |
- |
| Date | Value |
|---|
| Dec 31, 2023 |
-1.16 Mn |
| Sep 30, 2023 |
-1.07 Mn |
| Dec 31, 2020 |
-18,207.00 |
| Sep 30, 2020 |
-13,490.00 |
| Mar 31, 2020 |
-2,643.00 |
| Dec 31, 2019 |
4,636.00 |
| Sep 30, 2019 |
256.00 |
| Jun 30, 2019 |
1,283.00 |
| Mar 31, 2019 |
1,535.00 |
| Dec 31, 2018 |
1,677.00 |
| Sep 30, 2018 |
3,695.00 |
| Jun 30, 2018 |
3,944.00 |
| Mar 31, 2018 |
3,309.00 |
| Dec 31, 2017 |
-11,770.00 |
| Sep 30, 2017 |
2,779.00 |
| Jun 30, 2017 |
2,796.00 |
| Mar 31, 2017 |
-178.00 |
| Dec 31, 2016 |
-11,032.00 |
| Sep 30, 2016 |
-519.00 |
| Jun 30, 2016 |
-1,079.00 |
